Sign up to save your podcasts
Or
Share Today’s Clinical Trials Define the Next Era in Myeloma
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Today’s Clinical Trials Define the Next Era in Myeloma
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.
View all episodes
By Rahul Banerjee, MD
4.8
2727 ratings
In this Editor’s Special Episode of The HemOnc Pulse, Dr. Hira Mian of McMaster University shares expert insights on the evolving treatment landscape for multiple myeloma. From optimizing selinexor use, to understanding long-term MonumenTAL-1 data with talquetamab, to the promise of emerging trispecific antibodies, Dr. Mian highlights the biggest shifts shaping care today.
More shows like The HemOnc Pulse
View all
JAMA Editors' Summary
140 Listeners
NEJM This Week
324 Listeners
JAMA Clinical Reviews
498 Listeners
Hematologic Oncology Update
76 Listeners
Research To Practice | Oncology Videos
120 Listeners
The Hematologist
28 Listeners
Core IM | Internal Medicine Podcast
1,142 Listeners
OncoPharm
187 Listeners
OncLive® On Air
22 Listeners
Harrison's PodClass: Internal Medicine Cases and Board Prep
369 Listeners
Blood Podcast
52 Listeners
Healthcare Unfiltered
138 Listeners
Blood Cancer Talks
48 Listeners
Two Onc Docs
193 Listeners
WolverHeme Happy Hour
29 Listeners